Literature DB >> 28746019

Evaluation of a "Just-in-Time" Nurse Consultation on Bone Health: A Pilot Randomized Controlled Trial.

Douglas W Roblin1, David Zelman2, Sally Plummer3, Brandi E Robinson4, Yiyue Lou5, Stephanie W Edmonds6, Fredric D Wolinsky7, Kenneth G Saag8, Peter Cram9.   

Abstract

CONTEXT: Evidence is inconclusive whether a nurse consultation can improve osteoporosis-related patient outcomes.
OBJECTIVE: To evaluate whether a nurse consultation immediately after dual-energy x-ray absorptiometry (DXA) produced better osteoporosis-related outcomes than a simple intervention to activate adults in good bone health practices or usual care.
DESIGN: Pilot randomized controlled trial, conducted within the larger Patient Activation After DXA Result Notification (PAADRN) trial (NCT01507662). After DXA, consenting adults age 50 years or older were randomly assigned to 3 groups: nurse consultation, PAADRN intervention (mailed letter with individualized fracture risk and an educational brochure), or usual care (control). Nurse consultation included reviewing DXA results, counseling on bone health, and ordering needed follow-up tests or physician referrals. MAIN OUTCOME MEASURES: Change from baseline to 52 weeks in participant-reported osteoporosis-related pharmacotherapy, lifestyle, activation and self-efficacy, and osteoporosis care satisfaction.
RESULTS: Nurse consultation participants (n = 104) reported 52-week improvements in strengthening and weight-bearing exercise (p = 0.09), calcium intake (p < 0.01), osteoporosis knowledge (p = 0.04), activation (p < 0.01), dietary self-efficacy (p = 0.06), and osteoporosis care satisfaction (p < 0.01). Compared with PAADRN intervention participants (n = 39), nurse consultation participants had improved dietary self-efficacy (p = 0.07) and osteoporosis care satisfaction (p = 0.05). No significant improvements in osteoporosis-related outcomes were achieved vs PAADRN controls (n = 70).
CONCLUSION: "Just-in-time" nurse consultation yielded a few improvements over 52 weeks in osteoporosis-related outcomes; however, most changes were not different from those obtained through the lower-cost PAADRN intervention or usual care.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28746019      PMCID: PMC5528825          DOI: 10.7812/TPP/16-112

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  39 in total

1.  Tailored interventions to enhance osteoporosis prevention in women.

Authors:  Carol A Sedlak; Margaret O Doheny; Patricia J Estok; Richard A Zeller
Journal:  Orthop Nurs       Date:  2005 Jul-Aug       Impact factor: 0.913

2.  Perspectives on pre-fracture intervention strategies: the Geisinger Health System Osteoporosis Program.

Authors:  Eric D Newman
Journal:  Osteoporos Int       Date:  2011-08-17       Impact factor: 4.507

3.  Patient education in groups increases knowledge of osteoporosis and adherence to treatment: a two-year randomized controlled trial.

Authors:  Dorthe Nielsen; Jesper Ryg; Winnie Nielsen; Berit Knold; Nis Nissen; Kim Brixen
Journal:  Patient Educ Couns       Date:  2010-04-18

Review 4.  Methods to explain the clinical significance of health status measures.

Authors:  Gordon H Guyatt; David Osoba; Albert W Wu; Kathleen W Wyrwich; Geoffrey R Norman
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

5.  Outcomes of a nurse-led osteoporosis and falls assessment.

Authors:  Yasser El Miedany; Annie Gardiner; Maha El Gaafary; Mathias Toth
Journal:  Br J Nurs       Date:  2006 Oct 26-Nov 8

Review 6.  Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.

Authors:  Michael McClung; Steven T Harris; Paul D Miller; Douglas C Bauer; K Shawn Davison; Larry Dian; David A Hanley; David L Kendler; Chui Kin Yuen; E Michael Lewiecki
Journal:  Am J Med       Date:  2012-11-20       Impact factor: 4.965

7.  The PAADRN study: a design for a randomized controlled practical clinical trial to improve bone health.

Authors:  Stephanie W Edmonds; Fredric D Wolinsky; Alan J Christensen; Xin Lu; Michael P Jones; Douglas W Roblin; Kenneth G Saag; Peter Cram
Journal:  Contemp Clin Trials       Date:  2012-10-17       Impact factor: 2.226

8.  Improving bone mineral density reporting to patients with an illustration of personal fracture risk.

Authors:  Stephanie W Edmonds; Peter Cram; Xin Lu; Douglas W Roblin; Nicole C Wright; Kenneth G Saag; Samantha L Solimeo
Journal:  BMC Med Inform Decis Mak       Date:  2014-11-25       Impact factor: 2.796

9.  The role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapy.

Authors:  Ewa Sewerynek; Hanna Horst-Sikorska; Wioletta Stępień-Kłos; Agnieszka Antkowiak; Małgorzata Janik; Karol Cieślak; Michalina Marcinkowska; Agnieszka Cegłowska; Michał Stuss
Journal:  Arch Med Sci       Date:  2013-04-22       Impact factor: 3.318

10.  Developing a bone mineral density test result letter to send to patients: a mixed-methods study.

Authors:  Stephanie W Edmonds; Samantha L Solimeo; Xin Lu; Douglas W Roblin; Kenneth G Saag; Peter Cram
Journal:  Patient Prefer Adherence       Date:  2014-06-05       Impact factor: 2.711

View more
  2 in total

1.  Effect of coordinator-based osteoporosis intervention on quality of life in patients with fragility fractures: a prospective randomized trial.

Authors:  R Okuda; M Osaki; Y Saeki; T Okano; K Tsuda; T Nakamura; Y Morio; H Nagashima; H Hagino
Journal:  Osteoporos Int       Date:  2022-02-23       Impact factor: 4.507

Review 2.  Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review.

Authors:  Charlotte Beaudart; Mickael Hiligsmann; Nannan Li; E Michael Lewiecki; Stuart Silverman
Journal:  Osteoporos Int       Date:  2021-09-24       Impact factor: 4.507

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.